216 related articles for article (PubMed ID: 16360717)
1. Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis.
Clarke R; Leonessa F; Trock B
Semin Oncol; 2005 Dec; 32(6 Suppl 7):S9-15. PubMed ID: 16360717
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it.
Hait WN; Yang JM
Semin Oncol; 2005 Dec; 32(6 Suppl 7):S16-21. PubMed ID: 16360718
[TBL] [Abstract][Full Text] [Related]
3. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.
Litman T; Druley TE; Stein WD; Bates SE
Cell Mol Life Sci; 2001 Jun; 58(7):931-59. PubMed ID: 11497241
[TBL] [Abstract][Full Text] [Related]
4. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.
Allen JD; Brinkhuis RF; van Deemter L; Wijnholds J; Schinkel AH
Cancer Res; 2000 Oct; 60(20):5761-6. PubMed ID: 11059771
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance of tumor cells.
Szabó D; Keyzer H; Kaiser HE; Molnár J
Anticancer Res; 2000; 20(6B):4261-74. PubMed ID: 11205256
[TBL] [Abstract][Full Text] [Related]
6. ATP binding cassette transporters and drug resistance in breast cancer.
Leonessa F; Clarke R
Endocr Relat Cancer; 2003 Mar; 10(1):43-73. PubMed ID: 12653670
[TBL] [Abstract][Full Text] [Related]
7. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
8. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
[TBL] [Abstract][Full Text] [Related]
9. [Multidrug resistance protein (MRP)].
Abe T; Mori T; Hori S; Koike K; Kuwano M
Nihon Rinsho; 1997 May; 55(5):1077-82. PubMed ID: 9155156
[TBL] [Abstract][Full Text] [Related]
10. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity.
Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA
ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726
[TBL] [Abstract][Full Text] [Related]
11. [Drug resistance mediated by ABC transporters].
Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
[TBL] [Abstract][Full Text] [Related]
12. Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR).
Lee JJ; Swain SM
Semin Oncol; 2005 Dec; 32(6 Suppl 7):S22-6. PubMed ID: 16360719
[TBL] [Abstract][Full Text] [Related]
13. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters].
Ueda K
Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147
[TBL] [Abstract][Full Text] [Related]
14. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
[TBL] [Abstract][Full Text] [Related]
15. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
[TBL] [Abstract][Full Text] [Related]
17. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
18. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
Shen H; Lee FY; Gan J
J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
[TBL] [Abstract][Full Text] [Related]
19. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
Erić S; Kalinić M; Ilić K; Zloh M
SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
[TBL] [Abstract][Full Text] [Related]
20. ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?
Steinbach D; Legrand O
Leukemia; 2007 Jun; 21(6):1172-6. PubMed ID: 17429427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
